Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD)
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Summary: An important means of determining how amyloid‐beta peptide (Aβ) affects cells is to identify specific macromolecular targets and assess how Aβ interaction with such targets impacts on cellular functions. On the one hand, cell surface receptors interacting with extracellular Aβ have been identified, and their engagement by amyloid peptide can trigger intracellular signaling cascades. Recent evidence has indicated a potentially significant role for deposition of intracellular Aβ in cell stress associated with amyloidosis. Thus, specific intracellular targets of Aβ might also be of interest. Our review evaluates the potential significance of Aβ interaction with a mitochondrial enzyme termed Aβ‐binding alcohol dehydrogenase (ABAD), a member of the short‐chain dehydrogenase‐reductase family concentrated in mitochondria of neurones. Binding of Aβ to ABAD distorts the enzyme's structure, rendering it inactive with respect to its metabolic properties, and promotes mitochondrial generation of free radicals. Double transgenic mice in which increased levels of ABAD are expressed in an Aβ‐rich environment, the latter provided by a mutant amyloid precursor protein transgene, demonstrate accelerated decline in spatial learning/memory and pathologic changes. These data suggest that mitochondria ABAD, ordinarily a contributor to metabolic homeostasis, has the capacity to become a pathogenic factor in an Aβ‐rich environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432 · cited 12×
“Similarly, in the MPTP-induced murine model of Parkinsonism, overexpression of ABAD had a cytoprotective effect on neurones.”
BackgroundInfluentialRAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 1×
“In this regard, our laboratory identified Receptor for Advanced Glycation Endproducts (RAGE) as a multiligand receptor whose repertoire of ligands included crossed b-sheet fibrils (Yan et al. 1996; Schmidt et al. 2001).”
BackgroundSelf-citationProduction of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Self-citationPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 1×
“Overexpression of mAPP was achieved using mice made in the laboratory of Dr Lennart Mucke (Hsia et al. 1999).”
MethodIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“…al. 1997; Hartmann et al. 1997; Tienari et al. 1997; Wild-Bode et al. 1997), and intracellular Ab has been shown in brains from patients with AD and Down’s syndrome, as well as in transgenic mice overexpressing mAPP (Hammad et al. 1997; Gouras et al. 2000; D’Andrea et al. 2001; Gyure et al. 2001).”
BackgroundScavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727 · cited 1×
“…complex receptor and neurotrophin receptor (p75), have also been shown to bind Ab (Narindrasorasak et al. 1991; Buee et al. 1993; Snow et al. 1994, 1995; Boland et al. 1996; El Khoury et al. 1996; Paresce et al. 1996; Watson et al. 1997; Yaar et al. 1997; Matter et al. 1998; Wang et al. 2000).”
BackgroundParesce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Brain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · cited 1×
“For example, decreased activity of complex IV (cytochrome c oxidase or COX) has been observed in the central nervous system, and even in peripheral tissues, such as platelets, of patients with AD (Kish et al. 1992; Mutisya et al. 1994; Parker et al. 1994; Maurer et al. 2000; Bosetti et al. 2002).”
Background
Cited by
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940
“A direct link between A -induced toxicity and mitochondrial dysfunction in AD has been suggested by the interaction between mitochondrial A and a mitochondrial protein, ABAD (HSD17B10, 17 -hydroxysteroid dehydrogenase) (20, 21).”
BackgroundAmyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
Reddy, P. H., & Oliver, D. M. (2019) · Cells · doi:10.3390/cells8050488 · Cited by 496
“Yan and Stern also demonstrated that Aβ interaction with cyclophilin D is responsible for the interference with IMM complexes and reduction in ATP production [69].”
BackgroundFang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335
Self-citationA mitochondrial etiology of Alzheimer and Parkinson disease
Coskun, P., Wyrembak, J., Schriner, S. E., Chen, H.-W., Marciniack, C., LaFerla, F., & Wallace, D. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.008 · Cited by 302
Metadata
- Authors
- Yan, S. D., & Stern, D. M.
- Venue
- International Journal of Experimental Pathology
- Publisher
- Wiley
- Published
- 2005-05-24
- Volume
- 86
- Issue
- 3
- Pages
- 161-171
- ISSN
- 0959-9673 (ISSN-L)
- 1365-2613
- OpenAlex
- W1879947423
- Cited by
- 129
- References
- 22
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD). https://app.cochat.ai/papers/10.1111/j.0959-9673.2005.00427.x
- The paper
- Yan, S. D., & Stern, D. M. (2005). Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD). International Journal of Experimental Pathology. https://doi.org/10.1111/j.0959-9673.2005.00427.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.